efficacy and safety results from a phase ii, placebo-controlled study of onartuzumab plus first-line platinum-doublet chemotherapy in advanced squamous cell non–small-cell lung cancer
本文档由 svp507267 分享于2017-04-21 08:47
efficacy and safety results from a phase ii, placebo-controlled study of onartuzumab plus first-line platinum-doublet chemotherapy in advanced squamous cell non–small-cell lung cancer
分享：
君，已阅读到文档的结尾了呢~~